{
    "name": "desoximetasone",
    "comment": "Rx",
    "other_names": [
        "Topicort"
    ],
    "classes": [
        "Corticosteroids",
        "Topical"
    ],
    "source": "https://reference.medscape.com/drug/topicort-desoximetasone-343655",
    "pregnancy": {
        "common": [
            "There are no available data on use in pregnant women to evaluate for a drug-associated risk of major birth defects, miscarriage or adverse maternal or fetal outcomes; observational studies suggest maternal use of high to super-high potency topical steroids; may be associated with an increased risk of low birthweight infants; advise pregnant woman that therapy may increase potential risk of low birth weight infants and to use drug on the smallest area of skin and for shortest duration possible",
            "Desoximetasone has been shown to cause malformations and be embryotoxic in mice, rats, and rabbits when given by subcutaneous or dermal routes of administration at doses 3 to 30 times the human dose based on a body surface area comparison"
        ],
        "specific": []
    },
    "lactation": {
        "common": [
            "There is no information on presence of topically administered desoximetasone in human milk, effects on breastfed infant, or on milk production; not known whether topical administration of corticosteroids could result in sufficient systemic absorption to produce detectable quantities in breast milk; the developmental and health benefits of breastfeeding should be considered along with mother's clinical need for therapy and any potential adverse effects on breastfed infant from therapy or from underlying maternal condition",
            "To minimize potential exposure to breastfed infant via breast milk, use spray on smallest area of skin and for shortest duration possible while breastfeeding; advise breastfeeding women not to apply spray directly to nipple and areola to avoid direct infant exposure"
        ]
    },
    "warnings": {
        "black_box_warning": {
            "common": [],
            "specific": []
        },
        "contraindicators": {
            "common": [
                "Underlying infection",
                "Hypersensitivity",
                "Ophthalmic use"
            ],
            "specific": []
        },
        "cautions": {
            "common": [
                "Not recommended for use in patients <18 years of age due to high incidence of HPA axis suppression observed",
                "Children may exhibit greater susceptibility to corticosteroid-induced HPA axis suppression and Cushing's syndrome due to larger skin surface area to body weight ratio",
                "Use of topical corticosteroids, including may increase risk of posterior subcapsular cataracts and glaucoma; cataracts and glaucoma reported with postmarketing use of topical corticosteroid products; avoid contact with eyes; may cause eye irritation; advise patients to report any visual symptoms and consider referral to an ophthalmologist for evaluation",
                "Chronic topical corticosteroid therapy may interfere with growth and development in children",
                "Use med to very high potency for <2 wk to reduce local and systemic side effects",
                "Use low potency for chronic therapy",
                "Kaposi's sarcoma reported with prolonged corticosteroid therapy ",
                "Contact dermatitis may occur that cause treament failure",
                "Avoid medium to very high potency on face, folds, groin because can increase steroid absorption"
            ],
            "specific": []
        }
    },
    "interactions": [],
    "adverse effects": [
        {
            "name": "Skin atrophy",
            "percent": "2"
        },
        {
            "name": "Striae",
            "percent": null
        },
        {
            "name": "Acneform lesions",
            "percent": null
        },
        {
            "name": "Pruritus",
            "percent": null
        },
        {
            "name": "Irritation",
            "percent": null
        },
        {
            "name": "Miliaria",
            "percent": null
        },
        {
            "name": "Folliculitis",
            "percent": null
        },
        {
            "name": "Erythema",
            "percent": null
        },
        {
            "name": "Hypopigmentation",
            "percent": null
        },
        {
            "name": "Vesiculation",
            "percent": null
        },
        {
            "name": "Pigmentation changes",
            "percent": null
        },
        {
            "name": "HPA suppression",
            "percent": null
        },
        {
            "name": "with higher potency used",
            "percent": null
        },
        {
            "name": "wk",
            "percent": null
        },
        {
            "name": "Telangiectasias",
            "percent": null
        },
        {
            "name": "dryness",
            "percent": null
        },
        {
            "name": "perioral dermatitis",
            "percent": null
        },
        {
            "name": "secondary infection",
            "percent": null
        },
        {
            "name": "Cataracts",
            "percent": null
        },
        {
            "name": "glaucoma",
            "percent": null
        },
        {
            "name": "and increased intraocular pressure",
            "percent": null
        }
    ]
}